loading

Structure Therapeutics Inc Adr Borsa (GPCR) Ultime notizie

pulisher
Nov 20, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Assetmark Inc. Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Nov 19, 2024
pulisher
Nov 18, 2024

FY2024 Earnings Forecast for GPCR Issued By Lifesci Capital - Defense World

Nov 18, 2024
pulisher
Nov 17, 2024

GPCRStructure Therapeutics Inc. American Depositary Shares Latest Stock News & Market Updates - StockTitan

Nov 17, 2024
pulisher
Nov 16, 2024

Structure Therapeutics (NASDAQ:GPCR) Trading Down 8.9%Here's What Happened - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Structure Therapeutics to Present at Jefferies London Healthcare Conference | GPCR Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 14, 2024

GSA Capital Partners LLP Purchases Shares of 30,464 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Structure Therapeutics Reports Strong Q3 2024 Results - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Structure Therapeutics Advances Obesity Drug Trial, Reports $915M Cash Position | GPCR Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Structure Therapeutics Launches Phase 2b Obesity Drug Trial, Expands Testing to Higher Doses | GPCR Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 05, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Is Viking Therepautics a Buy Now? - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Oral Proteins and Peptides Market to Reach $28.17 Billion by 2031 As Revealed In New Report - WhaTech

Nov 05, 2024
pulisher
Nov 05, 2024

Some of the Major Key Players in the oral proteins and peptides market are - InsightAce Analytic

Nov 05, 2024
pulisher
Nov 03, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Position Increased by abrdn plc - MarketBeat

Nov 03, 2024
pulisher
Nov 01, 2024

Ballard Power Systems Inc (NASDAQ: BLDP) Has Great Upside Potential - Stocks Register

Nov 01, 2024
pulisher
Nov 01, 2024

Is Structure Therapeutics Inc ADR (NASDAQ: GPCR) A Good Investment For New Investors Now? - Stocks Register

Nov 01, 2024
pulisher
Oct 31, 2024

10 Best IPO Stocks To Buy Heading into 2025 - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

Biopharma Co. Can't Knock Ex-CFO's Bias Suit Out Of Court - Law360

Oct 30, 2024
pulisher
Oct 30, 2024

Armata Pharmaceuticals Announces Structural Biology Publication - StockTitan

Oct 30, 2024
pulisher
Oct 28, 2024

Secretome Therapeutics, Inc. Announces Composition of Matter Patents for Lead Assets STM-01 and STM-21 - Business Wire

Oct 28, 2024
pulisher
Oct 26, 2024

Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $86.80 - MarketBeat

Oct 26, 2024
pulisher
Oct 24, 2024

GPCR drugmaker Septerna amasses $288M in IPO - BioPharma Dive

Oct 24, 2024
pulisher
Oct 17, 2024

Griffin Asset Management Inc. Acquires New Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Structure Therapeutics Inc ADR (GPCR) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Oct 16, 2024
pulisher
Oct 16, 2024

Exchange Traded Concepts LLC Has $1.80 Million Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Structure Therapeutics Inc ADR Inc. (GPCR) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 15, 2024
pulisher
Oct 14, 2024

Daily Progress: Structure Therapeutics Inc ADR (GPCR) Drop -1.39, Closing at 38.32 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Is Structure Therapeutics Inc ADR (GPCR) a threat to investors? - US Post News

Oct 14, 2024
pulisher
Oct 11, 2024

Structure Therapeutics (NASDAQ:GPCR) Shares Down 2.7%Here's What Happened - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Structure Therapeutics Inc ADR: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle

Oct 11, 2024
pulisher
Oct 10, 2024

Top investors say Structure Therapeutics Inc ADR (GPCR) ticks everything they need - SETE News

Oct 10, 2024
pulisher
Oct 10, 2024

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch. - BioPharma Dive

Oct 10, 2024
pulisher
Oct 10, 2024

Weight Loss Drugs Market Top Trends 2024-2031 - InsightAce Analytic

Oct 10, 2024
pulisher
Oct 09, 2024

Market Recap Check: Structure Therapeutics Inc ADR (GPCR)’s Positive Finish at 40.50, Up/Down 0.30 - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect? - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Structure Therapeutics (NASDAQ:GPCR) Shares Up 3.7%Here's What Happened - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

The Manufacturers Life Insurance Company Buys 32,839 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Structure Therapeutics Inc ADR (GPCR) is a good investment, but the stock may be overvalued - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

27,094 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Bank of Montreal Can - MarketBeat

Oct 07, 2024
pulisher
Oct 05, 2024

35,700 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Bought by Renaissance Technologies LLC - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

Marshall Wace LLP Raises Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

3 AI Stocks to Buy as Nvidia Sputters - InvestorPlace

Oct 04, 2024
pulisher
Oct 02, 2024

Are Structure Therapeutics Inc ADR (GPCR) shares a good deal now? - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Structure Therapeutics (NASDAQ:GPCR) Trading 5.8% Higher - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

GentiBio Appoints Mark Bach, M.D., Ph.D., as Chief Medical Officer - BioSpace

Sep 30, 2024
pulisher
Sep 30, 2024

Nasdaq Global Select Market Composite Index (NQGS) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 30, 2024

S&P 100 Index (OEX) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 30, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 30, 2024

Ratios Uncovered: Breaking Down Structure Therapeutics Inc ADR (GPCR)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Structure Therapeutics Inc ADR (GPCR) expanding its growth trajectory ahead - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Perceptive Advisors LLC Makes New Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Perceptive Advisors LLC Acquires Shares of 34,852 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Structure Therapeutics' SWOT analysis: small-cap biotech's stock potential in obesity market - Investing.com

Sep 30, 2024
pulisher
Sep 29, 2024

18,803 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Purchased by Scientech Research LLC - MarketBeat

Sep 29, 2024
pulisher
Sep 29, 2024

Is Structure Therapeutics Inc. (GPCR) the Best Young Stock To Buy Now? - Insider Monkey

Sep 29, 2024
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):